![](https://www.mmm-online.com/wp-content/uploads/sites/2/2024/01/5-Things-Rx-Rundown_Jan-2024_Web-Art-fin-002-1280x900-1.png)
Rx Rundown: Daiichi Sankyo, Novartis, Eisai and more
Check out this week’s medical marketing news, dealmaking and industry chatter. Deals: Eisai signed a $1.5 billion pact with Seed Therapeutics for undisclosed neurodegeneration and oncology targets. Daiichi Sankyo announced it will pay Merck $170 million to …